Back

Can apoA-I infusion decrease cardiovascular events?

European Heart Journal

9 November 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Lale Tokgözoğlu
Lale Tokgözoğlu

Author

Angela Pirillo
Angela Pirillo

Author

Alberico L Catapano
Alberico L Catapano

Author

IRCCS - MultiMedica Milan , Italy

You may be interested in
thumbnail
Congress Presentation
Boosting secondary prevention: efficacy and adherence of inclisiran in post-acute coronary syndrome very high-risk patients
3 April 2025
thumbnail
Congress Presentation
Apolipoprotein B and cardiovascular risk in asymptomatic patients: need for systematic evaluation?
14 April 2023
thumbnail
Congress Presentation
Cardiovascular events in patients diagnosed with light chain amyloidosis in the USA: a real-world analysis utilizing electronic health records
20 June 2025
thumbnail
Congress Presentation
Lipoprotein(a), are its levels really invariable?
25 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources